兴齐眼药
(300573)
| 流通市值：96.78亿 | | | 总市值：126.28亿 |
| 流通股本：2.72亿 | | | 总股本：3.55亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,400,873,956.41 | 683,337,441.58 | 2,472,852,236.79 | 1,903,728,804.18 |
| 营业收入 | 1,400,873,956.41 | 683,337,441.58 | 2,472,852,236.79 | 1,903,728,804.18 |
| 二、营业总成本 | 921,296,880.83 | 456,989,442.88 | 1,667,470,697.01 | 1,215,800,734.13 |
| 营业成本 | 248,077,845.85 | 122,644,319.06 | 465,962,118.19 | 355,470,544.74 |
| 税金及附加 | 19,330,670.08 | 9,244,272.6 | 32,831,651.69 | 26,879,833.5 |
| 销售费用 | 413,478,661.58 | 199,598,174.58 | 763,972,611.16 | 555,474,170.54 |
| 管理费用 | 80,794,547.85 | 41,752,758.11 | 174,547,138.04 | 118,939,414.98 |
| 研发费用 | 161,302,852.97 | 84,474,178.33 | 225,910,095.09 | 155,124,563.1 |
| 财务费用 | -1,687,697.5 | -724,259.8 | 4,247,082.84 | 3,912,207.27 |
| 其中:利息费用 | 676,984.56 | 481,320.49 | 4,435,786.8 | 3,804,566.19 |
| 其中:利息收入 | 861,905.81 | 408,353.82 | 2,252,622.99 | 1,853,220.02 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 5,126,142.18 | - | - | - |
| 资产处置收益 | 7,973.32 | - | 52,536.38 | 74,560.73 |
| 资产减值损失(新) | -509,433.41 | -30,626.73 | -15,176,291.68 | -7,765,922.42 |
| 信用减值损失(新) | -1,288,063.05 | -526,819.54 | -2,174,108.55 | -4,776,248.77 |
| 其他收益 | 12,101,457.62 | 6,787,149.17 | 34,138,553.38 | 28,007,361.32 |
| 四、营业利润 | 495,015,152.24 | 232,577,701.6 | 822,222,229.31 | 703,467,820.91 |
| 加:营业外收入 | 10,000 | 10,000 | 517,251.63 | 183,758 |
| 减:营业外支出 | 12,726,436.78 | 2,468,274.91 | 22,463,807.22 | 14,880,706.36 |
| 五、利润总额 | 482,298,715.46 | 230,119,426.69 | 800,275,673.72 | 688,770,872.55 |
| 减:所得税费用 | 51,894,422.1 | 23,705,152.2 | 104,420,077.47 | 89,864,486.4 |
| 六、净利润 | 430,404,293.36 | 206,414,274.49 | 695,855,596.25 | 598,906,386.15 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 430,404,293.36 | 206,414,274.49 | 695,855,596.25 | 598,906,386.15 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 430,404,293.36 | 206,414,274.49 | 695,855,596.25 | 598,906,386.15 |
| 扣除非经常损益后的净利润 | 431,589,421.95 | 206,363,102.71 | 697,046,957.34 | 596,091,025.14 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.2 | 0.84 | 2.83 | 2.44 |
| (二)稀释每股收益 | 1.2 | 0.84 | 2.83 | 2.44 |
| 八、其他综合收益 | - | - | 1,416,666.67 | - |
| 归属于母公司股东的其他综合收益 | - | - | 1,416,666.67 | - |
| 九、综合收益总额 | 430,404,293.36 | 206,414,274.49 | 697,272,262.92 | 598,906,386.15 |
| 归属于母公司股东的综合收益总额 | 430,404,293.36 | 206,414,274.49 | 697,272,262.92 | 598,906,386.15 |
| 公告日期 | 2026-08-28 | 2026-04-28 | 2026-04-22 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |